cleveland clinic glp-1 study shows promise for weight loss, but can you believe the hype? Cleveland Clinic Research Finds Injectable

The limited treatment landscape has created significant interest in repurposing existing drugs, particularly glucagon-like peptide-1 (GLP-1) receptor agonists, which address multiple metabolic pathways implicated in fatty liver disease

As many as 3050% of depressed patients respond only partially to antidepressants, leaving them with substantial residual symptoms (Davis et al., 2021)

Neural Regeneration Research , 17(3), 482

Correlation between AGEs and feature of PCOS PCOS has been defined as a disorder due to an excess of androgens and insulin resistance, about 5070% of women with PCOS have a certain degree of resistance to insulin, which is defined as a state in which more insulin is required than the normal to obtain an appropriate response [47]

58(3): 2014 Brooks DE, Mclntosh JE

This is a cocktail I can get behind